SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

2.

Rural-urban disparities seen in cervical cancer

3.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

4.

Legal, Recreational Marijuana Linked to Higher CUD Prevalence.

5.

Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot